At a glance
ClinicalIndex Comparison RecordN/ACompleted· 103 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow-up
In Brief
An observational study for Diabetes Mellitus and 3 related conditions. Completed, enrolled 103 participants across 1 site.
Detailed Summary
The purpose of this study is to identify risk factors for insulin resistance and to investigate the influence of insulin sensitivity on development of cardiovascular risk markers like blood pressure, heart rate, body build (weight, BMI, waist-hip ratio, skinfold thickness), reduced insulin sensitivity, diabetes mellitus, dyslipidaemia, and sympathoadrenal activity or manifest cardiovascular disease among young men during 10-20 years.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Hypertension, Ischemic Heart Disease, Stroke
CountriesNorway
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedAug 2011
Primary CompletionMar 2014
Study CompletionMar 2015
TodayJul 2026
First PostedAug 9, 2011
Enrollment StartAug 1, 2011
Primary CompletionMar 1, 2014
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 14.9 years ago